MAST THERAPEUTICS INC's ticker is MSTX and the CUSIP is 576314108. A total of 39 filers reported holding MAST THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $211,000 | +32.7% | 449,084 | -22.8% | 0.05% | +6.1% |
| Q1 2016 | $159,000 | -35.1% | 581,886 | 0.0% | 0.05% | -24.6% |
| Q4 2015 | $245,000 | -27.3% | 581,886 | 0.0% | 0.06% | -27.8% |
| Q3 2015 | $337,000 | +18.2% | 581,886 | 0.0% | 0.09% | +66.7% |
| Q2 2015 | $285,000 | +1.1% | 581,886 | 0.0% | 0.05% | +8.0% |
| Q1 2015 | $282,000 | -13.5% | 581,886 | 0.0% | 0.05% | -3.8% |
| Q4 2014 | $326,000 | +0.6% | 581,886 | 0.0% | 0.05% | +23.8% |
| Q3 2014 | $324,000 | +0.6% | 581,886 | +13.5% | 0.04% | +23.5% |
| Q2 2014 | $322,000 | -7.5% | 512,476 | 0.0% | 0.03% | -15.0% |
| Q1 2014 | $348,000 | +41.5% | 512,476 | -3.8% | 0.04% | +29.0% |
| Q4 2013 | $246,000 | -7.2% | 532,776 | -11.6% | 0.03% | -27.9% |
| Q3 2013 | $265,000 | -31.0% | 602,776 | -32.6% | 0.04% | -43.4% |
| Q2 2013 | $384,000 | – | 894,401 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,294,934 | $599,000 | 0.42% |
| Ancora Advisors LLC | 1,234,599 | $571,000 | 0.09% |
| Alyeska Investment Group, L.P. | 1,900,000 | $1,757,000 | 0.07% |
| THOMPSON DAVIS & CO., INC. | 80,000 | $37,000 | 0.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,466,249 | $678,000 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 532,776 | $246,000 | 0.03% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 123,450 | $57,000 | 0.02% |
| WEXFORD CAPITAL LP | 89,360 | $41,000 | 0.00% |
| FRANKLIN RESOURCES INC | 12,046,100 | $5,570,000 | 0.00% |
| Renaissance Technologies | 1,535,000 | $710,000 | 0.00% |